EDUCATIONAL OBJECTIVES
After attending this activity, participants should be able to:
- Properly evaluate the cardiometabolic risk associated with abdominal obesity and features of the metabolic syndrome.
- Understand the pathophysiology of abdominal obesity and related metabolic complications.
- Discuss how to assess cardiometabolic risk among abdominally obese patients.
- Discuss the management of abdominal obesity, type 2 diabetes and global cardiometabolic risk (diet/nutrition, physical activity/exercise, pharmacotherapy).
ACCREDITATION STATEMENT AND CREDIT DESIGNATION
The Office of the vice-dean of education and professional development at the Faculty of Medicine of Université Laval follows the rules of Ethic code for parties involved in the continuing medical education of Québec, guidelines of the Canadian Medical Association for physicians in interactions with industry and Policies on interactions between members of the Faculty of Medicine of Université Laval and private industry.
The Office of the vice-dean of education and professional development at the Faculty of Medicine of Université Laval will acknowledge category 1 credits in medical education for this activity.
The Office of the vice-dean of education and professional development at the Faculty of Medicine of Université Laval is supported by the College of Physicians of Québec, the Committee on Accreditation of Canadian Medical Schools (CACMS), by the Accreditation Council for Continuing Medical Education (ACCME) of the United States, and is authorized by these organizations to offer activities in medical education for physicians.
FACULTY DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION
The ICAO 2012 Congress Scientific Committee is committed to ensuring balance, independence, objectivity, and scientific rigor in all of its continuing medical education activities. Accordingly, those in control of the educational content must disclose all relevant affiliations and relevant financial relationships with any commercial interest. Disclosure of this information is made to participants verbally at the beginning of each educational session.
View Updated Faculty Disclosure Information. Click here for the template Disclosure Slide.
COMMERCIAL SUPPORT DISCLOSURE
Sponsors of the industry are not involved and have no influence in the development of the scientific program of the congress which is under the control of the ICAO 2012 Congress Scientific Committee.
DISCLAIMER
The information provided during this CME activity is for continuing medical education purposes only. It is not meant to substitute for the independent medical judgment of a health care provider relative to diagnostic and treatment options for a specific patient's medical condition.
CME Credit Breakdown
Journée Franco-Québécoise (French)
|
Monday, July 9, 2012 |
Credits |
|
14:00-14:05 |
INTRODUCTION |
2.1 |
|
14:05-14:55 |
1- ÉPIDÉMIOLOGIE DE L’OBÉSITÉ ET DE L’ADIPOSITÉ ABDOMINALE |
|
14:55-16:05 |
2- OBÉSITÉ ABDOMINALE, GRAISSE ECTOPIQUE : ASPECTS PATHOPHYSIOLOGIQUES |
|
16:20-17:30 |
3- OBÉSITÉ ABDOMINALE EN CARDIOLOGIE |
2.0 |
|
17:30-18:20 |
4- OBÉSITÉ MASSIVE : ÉVALUATION/PRISE EN CHARGE |
|
18:20-18:45 |
RÉSUMÉ DES MESSAGES-CLÉS |
0.4 |
|
Total |
4.5 |
ICAO 2012 Timetable
|
Tuesday, July 10, 2012 |
Credits |
|
17:30-20:00 |
Session 1: ASSESSMENT OF ABDOMINAL OBESITY, METABOLIC SYNDROME AND RELATED CARDIOMETABOLIC RISK |
2.5 |
|
Total |
2.5 |
|
Wednesday, July 11, 2012 |
|
08:15-10:15 |
Session 2: PATHOPHYSIOLOGY OF ABDOMINAL OBESITY AND RELATED CARDIOMETABOLIC RISK |
2.0 |
|
10:15-10:45 |
Coffee Break, Poster Viewing, Exhibition Visit |
0.5 |
|
10:45-12:45 |
Session 2: PATHOPHYSIOLOGY OF ABDOMINAL OBESITY AND RELATED CARDIOMETABOLIC RISK (contd.) |
2.0 |
|
12:45-13:45 |
Lunch Break, Poster Viewing, Exhibition Visit, Discussed Poster Presentation Session |
1.0 |
|
13:45-15:45 |
Session 3: ASSESSMENT OF GLOBAL CARDIOMETABOLIC RISK: EPIDEMIOLOGICAL EVIDENCE |
2.0 |
|
15:45-16:15 |
Coffee Break, Poster Viewing, Exhibition Visit |
0.5 |
|
16:15- 18.15 |
Session 3: ASSESSMENT OF GLOBAL CARDIOMETABOLIC RISK: EPIDEMIOLOGICAL EVIDENCE (contd.) |
2.0 |
|
Total |
10.0 |
|
Thursday, July 12, 2012 |
|
08:15-10:30 |
Session 4: CLINICAL MANAGEMENT OF CVD RISK IN ABDOMINAL OBESITY AND TYPE 2 DIABETES |
2.25 |
|
10:30-11:00 |
Coffee Break, Poster Viewing, Exhibition Visit |
0.5 |
|
11:00-12:30 |
Session 5: MANAGEMENT OF ABDOMINAL OBESITY AND GLOBAL CARDIOMETABOLIC RISK: PHYSICAL ACTIVITY/EXERCISE |
1.5 |
|
12:30-13:30 |
Lunch Break, Poster Viewing, Exhibition Visit, Discussed Poster Presentation Session |
1.0 |
|
13:30-15:00 |
Session 6: NUTRITIONAL MANAGEMENT OF ABDOMINAL OBESITY AND TYPE 2 DIABETES: FROM DIETING TO EATING HEALTHY |
1.5 |
|
15:00-15:30 |
Coffee Break, Poster Viewing, Exhibition Visit |
0.5 |
|
15:30-17:45 |
Session 6: NUTRITIONAL MANAGEMENT OF ABDOMINAL OBESITY AND TYPE 2 DIABETES: FROM DIETING TO EATING HEALTHY (contd.) |
2.25 |
|
Total |
9.5 |